237 related articles for article (PubMed ID: 31930455)
21. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
[TBL] [Abstract][Full Text] [Related]
22. Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease.
Araya N; Sato T; Yagishita N; Ando H; Utsunomiya A; Jacobson S; Yamano Y
Viruses; 2011 Sep; 3(9):1532-48. PubMed ID: 21994794
[TBL] [Abstract][Full Text] [Related]
23. Early Onset of HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) and Adult T-cell Leukemia/Lymphoma (ATL): Systematic Search and Review.
Oliveira PD; Kachimarek AC; Bittencourt AL
J Trop Pediatr; 2018 Apr; 64(2):151-161. PubMed ID: 28582585
[TBL] [Abstract][Full Text] [Related]
24. HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy.
Kubota R; Umehara F; Izumo S; Ijichi S; Matsumuro K; Yashiki S; Fujiyoshi T; Sonoda S; Osame M
J Neuroimmunol; 1994 Aug; 53(1):23-9. PubMed ID: 7914211
[TBL] [Abstract][Full Text] [Related]
25. T cell receptor repertoire analysis in HTLV-1-associated diseases.
Clauze A; Enose-Akahata Y; Jacobson S
Front Immunol; 2022; 13():984274. PubMed ID: 36189294
[TBL] [Abstract][Full Text] [Related]
26. Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, Brazil.
Araújo Ade Q; Alfonso CR; Schor D; Leite AC; de Andrada-Serpa MJ
Acta Neurol Scand; 1993 Jul; 88(1):59-62. PubMed ID: 8372632
[TBL] [Abstract][Full Text] [Related]
27. Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP.
Nagai M; Yamano Y; Brennan MB; Mora CA; Jacobson S
Ann Neurol; 2001 Dec; 50(6):807-12. PubMed ID: 11761481
[TBL] [Abstract][Full Text] [Related]
28. An altered maturation and adhesion phenotype of dendritic cells in diseased individuals compared to asymptomatic carriers of human T cell leukemia virus type 1.
Manuel SL; Sehgal M; Khan ZK; Goedert JJ; Betts MR; Jain P
AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1273-85. PubMed ID: 23750452
[TBL] [Abstract][Full Text] [Related]
29. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy.
Kira J; Itoyama Y; Koyanagi Y; Tateishi J; Kishikawa M; Akizuki S; Kobayashi I; Toki N; Sueishi K; Sato H
Ann Neurol; 1992 Jan; 31(1):39-45. PubMed ID: 1543349
[TBL] [Abstract][Full Text] [Related]
30. Mediators of central nervous system damage during the progression of human T-cell leukemia type I-associated myelopathy/tropical spastic paraparesis.
Barmak K; Harhaj EW; Wigdahl B
J Neurovirol; 2003 Oct; 9(5):522-9. PubMed ID: 13129766
[TBL] [Abstract][Full Text] [Related]
31. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
[TBL] [Abstract][Full Text] [Related]
32. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
Takamori A; Hasegawa A; Utsunomiya A; Maeda Y; Yamano Y; Masuda M; Shimizu Y; Tamai Y; Sasada A; Zeng N; Choi I; Uike N; Okamura J; Watanabe T; Masuda T; Kannagi M
Retrovirology; 2011 Dec; 8():100. PubMed ID: 22151736
[TBL] [Abstract][Full Text] [Related]
33. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.
Goncalves DU; Proietti FA; Barbosa-Stancioli EF; Martins ML; Ribas JG; Martins-Filho OA; Teixeira-Carvalho A; Peruhype-Magalhães V; Carneiro-Proietti AB
Inflamm Allergy Drug Targets; 2008 Jun; 7(2):98-107. PubMed ID: 18691139
[TBL] [Abstract][Full Text] [Related]
34. Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) progression.
Gomes YCP; Freitas NL; Souza FS; Sandim V; Pereira DA; Nogueira FCS; Echevarria-Lima J; Leite ACCB; Lima MASD; Silva MTT; Araújo AQC; Vicente ACP; Espíndola OM
Front Immunol; 2022; 13():949516. PubMed ID: 36052089
[TBL] [Abstract][Full Text] [Related]
35. Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Enose-Akahata Y; Jacobson S
Retrovirology; 2019 Nov; 16(1):35. PubMed ID: 31783764
[TBL] [Abstract][Full Text] [Related]
36. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
[TBL] [Abstract][Full Text] [Related]
37. Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases.
Bellon M; Bialuk I; Galli V; Bai XT; Farre L; Bittencourt A; Marçais A; Petrus MN; Ratner L; Waldmann TA; Asnafi V; Gessain A; Matsuoka M; Franchini G; Hermine O; Watanabe T; Nicot C
Mol Cancer; 2021 Jun; 20(1):86. PubMed ID: 34092254
[TBL] [Abstract][Full Text] [Related]
38. Association of CD40 ligand expression on HTLV-I-infected T cells and maturation of dendritic cells.
Makino M; Utsunomiya A; Maeda Y; Shimokubo S; Izumo S; Baba M
Scand J Immunol; 2001 Dec; 54(6):574-81. PubMed ID: 11902332
[TBL] [Abstract][Full Text] [Related]
39. Human T-cell lymphotropic virus type I and neurological diseases.
Nagai M; Osame M
J Neurovirol; 2003 Apr; 9(2):228-35. PubMed ID: 12707853
[TBL] [Abstract][Full Text] [Related]
40. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
